Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2a Study of mRNA-1273 SARS-CoV-2 Vaccine
NCT04405076Phase 2Completed
- Sponsor
- Moderna Inc
- Start
- May 2020
- Primary completion
- Oct 2021
- Modality
- Vaccines & Immunotherapeutics, mRNA Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of elasomeran in coronavirus disease 2019 (COVID-19), sponsored by Moderna Inc. Started May 2020; status: completed.
02
Drugs
elasomeran
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04405076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04405076.